The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome. [electronic resource]
Producer: 20170123Description: 1-7 p. digitalISSN:- 1308-5263
- Abortion, Habitual -- etiology
- Animals
- Antibodies, Antiphospholipid -- immunology
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antiphospholipid Syndrome -- complications
- Clinical Trials as Topic
- Complement C5a -- antagonists & inhibitors
- Complement Inactivating Agents -- therapeutic use
- Complement Pathway, Classical -- drug effects
- Disease Models, Animal
- Female
- Hemoglobinuria, Paroxysmal -- drug therapy
- Humans
- Male
- Mice
- Multicenter Studies as Topic
- Observational Studies as Topic
- Placental Insufficiency -- etiology
- Pregnancy
- Receptor, Anaphylatoxin C5a -- physiology
- Thrombophilia -- etiology
- Thrombotic Microangiopathies -- drug therapy
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.